To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RSL24D1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
318 supporting clones for gene RSL24D1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG776350 lung, mucoepidermoid carcinoma .a 1 to 549 1 to 549   tiling clone,   549/549
(100 %)
4 diff
(99.3 %id)
BM542845 embryonal carcinoma, cell line, testis .a 9 to 802 1 to 799 G140X V157G D161N     799/1100
(72 %)
31 diff
(97.2 %id)
BM696576 eye, lens .a 36 to 715 1 to 680 exact     680/680
(100 %)
5 diff
(99.3 %id)
AF165521   .a 37 to 1485 1 to 1447 exact AAA   1447/1447
(100 %)
6 diff
(99.6 %id)
AF201949   .a 37 to 1032 1 to 996 exact AAA   996/996
(100 %)
0 diff
(100 %id)
AF212226 Liver .a 37 to 1508 1 to 1474 exact tiling clone,   1474/1474
(100 %)
1 diff
(100.0 %id)
F06423 brain, total brain .a 37 to 393 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
F08453 brain, total brain .a 37 to 365 1 to 330       330/330
(100 %)
1 diff
(99.7 %id)
NM_016304.2   .a 37 to 1500 1 to 1464 exact RefSeq, AAA   1464/1464
(100 %)
0 diff
(100 %id)
BF209562 bone marrow, from chronic myelogenous leukemia .a 111 to 632 1 to 536       532/919
(57 %)
28 diff
(97.0 %id)
BC008409 Bone marrow, chronic myelogenous leukemia .a 115 to 1500 1 to 1387 exact available from MGC, AAA   1387/1387
(100 %)
1 diff
(100.0 %id)
TI_44168680   .a 115 to 828 90 to 804 exact     715/804
(88 %)
8 diff
(99.1 %id)
BC008499 Brain, primitive neuroectodermal .a 124 to 1032 1 to 909 F29I available from MGC, AAA   909/909
(100 %)
2 diff
(99.8 %id)
BC035995 Lung, mucoepidermoid carcinoma .a 124 to 1485 1 to 1362 exact available from MGC, AAA   1362/1362
(100 %)
0 diff
(100 %id)
FN116689 breast carcinoma .a 124 to 212 94 to 6     Submitted on the opposite strand 89/94
(94 %)
0 diff
(100 %id)
BG503148 embryonal carcinoma, testis .a 124 to 872 1 to 757 exact     757/758
(99 %)
13 diff
(98.3 %id)
FN090934 breast carcinoma .a 127 to 208 1 to 83       83/84
(98 %)
2 diff
(97.7 %id)
DA613917   .a 127 to 702 2 to 577 E84X capped   576/576
(100 %)
0 diff
(100 %id)
BG529334 embryonal carcinoma, testis .a 128 to 684 1 to 569 K42N K43E R44A N45Q P46S ...     563/710
(79 %)
28 diff
(96.1 %id)
BP208421 cerebellum .a 129 to 699 1 to 571 exact     571/571
(100 %)
0 diff
(100 %id)
BP308358 brain .a 129 to 716 1 to 588 exact     588/588
(100 %)
0 diff
(100 %id)
BM761460 lymph node, stomach .a 129 to 820 1 to 692 exact     692/692
(100 %)
0 diff
(100 %id)
BX437495 thymus .a 130 to 968 1 to 839 L153X     839/839
(100 %)
0 diff
(100 %id)
FN173657 breast carcinoma .a 130 to 216 1 to 87       87/87
(100 %)
4 diff
(95.5 %id)
DA614710   .a 130 to 692 2 to 564 exact capped   563/563
(100 %)
0 diff
(100 %id)
FN147539 breast carcinoma .a 131 to 220 1 to 89       89/89
(100 %)
5 diff
(94.4 %id)
BF242961 bone marrow, from acute myelogenous leukemia .a 131 to 749 1 to 618 N115T K116T E117K L118E Q119L ...     614/818
(75 %)
32 diff
(96.1 %id)
BC016725 Bone marrow, acute myelogenous leukemia .a 132 to 1500 5 to 1369 exact available from MGC, AAA   1365/1365
(100 %)
4 diff
(99.8 %id)
BG615096 embryonal carcinoma, testis .a 132 to 733 1 to 623 K35T C36M H37S K38*     551/946
(58 %)
42 diff
(95.6 %id)
BC016312 Bone marrow, chronic myelogenous leukemia .a 133 to 1500 5 to 1372 W86R available from MGC, AAA   1368/1368
(100 %)
1 diff
(100.0 %id)
BC016331 Bone marrow, acute myelogenous leukemia .a 133 to 1500 5 to 1372 exact available from MGC, AAA   1368/1368
(100 %)
0 diff
(100 %id)
BC026266 Brain, primitive neuroectodermal .a 133 to 1500 1 to 1368 exact available from MGC, AAA   1368/1368
(100 %)
0 diff
(100 %id)
BC005344 Lung, mucoepidermoid carcinoma .a 133 to 1500 1 to 1368 Q151* available from MGC, AAA   1368/1368
(100 %)
4 diff
(99.8 %id)
BG527098 lung, mucoepidermoid carcinoma .a 133 to 767 1 to 644 I99N K100Q Q101T K102E R103A ...     640/648
(98 %)
16 diff
(97.6 %id)
BG614728 embryonal carcinoma, testis .a 133 to 891 1 to 759 exact     759/764
(99 %)
11 diff
(98.6 %id)
BP193837 brain .a 134 to 715 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BC009593 Bone marrow, acute myelogenous leukemia .a 134 to 1500 1 to 1367 exact available from MGC, AAA   1367/1367
(100 %)
2 diff
(99.9 %id)
BC009604 Brain, primitive neuroectodermal .a 134 to 1500 1 to 1368 exact available from MGC, AAA   1368/1368
(100 %)
2 diff
(99.9 %id)
FN048147 breast carcinoma .a 134 to 223 90 to 1     Submitted on the opposite strand 90/91
(98 %)
2 diff
(97.9 %id)
TI_44343390   .a 134 to 916 95 to 876 P15H R23G N115*     782/876
(89 %)
18 diff
(98.0 %id)
AV761289 bone marrow .a 134 to 914 1 to 774 exact     774/777
(99 %)
14 diff
(98.2 %id)
BP338113 Spleen .a 134 to 716 1 to 583 exact     583/583
(100 %)
0 diff
(100 %id)
BP338625 Spleen .a 134 to 713 1 to 580 exact     580/580
(100 %)
0 diff
(100 %id)
TI_149305193   .a 134 to 990 63 to 914 F29L   Submitted on the opposite strand 852/1045
(81 %)
28 diff
(97.4 %id)
BP376707 uterus .a 134 to 701 1 to 568 exact     568/568
(100 %)
0 diff
(100 %id)
AK315431 brain .a 137 to 671 1 to 535 exact     535/535
(100 %)
1 diff
(99.9 %id)
BG529606 embryonal carcinoma, testis .a 138 to 827 1 to 692 K114N N115T K116T E117K L118E ...     688/692
(99 %)
14 diff
(98.0 %id)
BC008449 Bone marrow, chronic myelogenous leukemia .a 139 to 1508 1 to 1370 exact available from MGC, AAA   1370/1370
(100 %)
1 diff
(100.0 %id)
BC014576 Brain, primitive neuroectodermal .a 139 to 799 5 to 665 R30G available from MGC, AAA   661/661
(100 %)
3 diff
(99.6 %id)
BU159148 eye, retinoblastoma .a 139 to 1034 1 to 899 exact     899/899
(100 %)
14 diff
(98.5 %id)
FN128213 breast carcinoma .a 142 to 205 64 to 1     Submitted on the opposite strand 64/78
(82 %)
0 diff
(100 %id)
CR612184 HeLa cells Cot 25-normalized .a 144 to 1244 1 to 1101 exact     1101/1101
(100 %)
0 diff
(100 %id)
CR621791 Placenta Cot 25-normalized .a 144 to 1225 1 to 1082 exact     1082/1082
(100 %)
0 diff
(100 %id)
BX336589 Placenta Cot 25-normalized .a 144 to 955 1 to 820 N45Q P46S R47S K48A V49K ...     820/931
(88 %)
14 diff
(98.5 %id)
BX342047   .a 144 to 1159 1 to 1007 exact     1007/1075
(93 %)
14 diff
(98.7 %id)
BC008422 Bone marrow, chronic myelogenous leukemia .a 145 to 1500 1 to 1354 exact available from MGC, AAA   1354/1354
(100 %)
1 diff
(100.0 %id)
BQ423825 eye, retinoblastoma .a 147 to 912 1 to 775 exact     775/929
(83 %)
24 diff
(97.5 %id)
BX404157 neuroblastoma .a 148 to 1270 1 to 1117 exact     1117/1117
(100 %)
7 diff
(99.4 %id)
BX407491 neuroblastoma .a 148 to 1200 1 to 1036 exact     1036/1073
(96 %)
20 diff
(98.2 %id)
CR599165 neuroblastoma .a 148 to 1496 1 to 1349 exact     1349/1349
(100 %)
0 diff
(100 %id)
BU175486 eye, retinoblastoma .a 148 to 1102 1 to 956 exact     956/956
(100 %)
8 diff
(99.2 %id)
AK055713   .a 150 to 1500 1 to 1350 R44C available from FLJ,   1350/1350
(100 %)
4 diff
(99.8 %id)
BC093067 Blood, peripheral blood mononuclear cells(PBMC) cytoplasmic poly A RNA is pooled sample from 3 and6 hr after stimulation with PMA and Ionomycin. Thesereagents are used to activate T- cells that results inlymphokine and cytokine production. .a 150 to 1509 1 to 1355 exact AAA   1355/1355
(100 %)
9 diff
(99.4 %id)
BE958407 brain, primitive neuroectoderm .a 150 to 786 1 to 645 Y7H F8S C9L S10F P12A ...     639/688
(92 %)
45 diff
(93.5 %id)
FN126887 breast carcinoma .a 151 to 234 1 to 86       86/86
(100 %)
4 diff
(95.4 %id)
BE890828 melanotic melanoma, skin .a 151 to 676 1 to 526 exact     526/526
(100 %)
0 diff
(100 %id)
BF211855 bone marrow, from chronic myelogenous leukemia .a 151 to 749 1 to 601 I3T Y7H C26A K27R V28C ...     599/888
(67 %)
39 diff
(95.7 %id)
DA604833   .a 151 to 656 2 to 508   capped   507/507
(100 %)
2 diff
(99.7 %id)
BC016777 Bone marrow, acute myelogenous leukemia .a 152 to 1500 6 to 1354 exact available from MGC, AAA   1349/1349
(100 %)
0 diff
(100 %id)
BC028672 Bladder, carcinoma .a 152 to 1485 5 to 1338 N45D E146G available from MGC, AAA   1334/1334
(100 %)
3 diff
(99.8 %id)
BG505294 embryonal carcinoma, testis .a 152 to 931 1 to 785 K113N K114E K116T E117K L118E ...     781/785
(99 %)
20 diff
(97.5 %id)
BM511020 insulinoma, Pancreas .a 152 to 704 8 to 560 exact     553/560
(98 %)
6 diff
(99.0 %id)
BU165325 eye, retinoblastoma .a 152 to 954 1 to 812 exact     812/904
(89 %)
19 diff
(97.9 %id)
TI_45216304   .a 152 to 961 130 to 942 exact     813/1153
(70 %)
24 diff
(98.0 %id)
BC026267 Brain, primitive neuroectodermal .a 154 to 1500 1 to 1347 exact available from MGC, AAA   1347/1347
(100 %)
1 diff
(100.0 %id)
BF173767 blood .a 156 to 289 1 to 134       134/136
(98 %)
7 diff
(94.9 %id)
BI857354 breast, mammary adenocarcinoma, cell line .a 156 to 954 1 to 801 exact     801/802
(99 %)
4 diff
(99.6 %id)
TI_57187664   .a 156 to 954 54 to 854 exact     801/802
(99 %)
4 diff
(99.6 %id)
CR991112 T-Lymphocytes .a 156 to 1081 1 to 928 exact     928/928
(100 %)
5 diff
(99.5 %id)
AA316414 colon .a 158 to 610 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BG257536 embryonal carcinoma, cell line, testis .a 158 to 940 1 to 776 exact     776/786
(98 %)
23 diff
(97.1 %id)
BU195683 eye, retinoblastoma .a 158 to 990 1 to 834 exact     834/835
(99 %)
2 diff
(99.8 %id)
DN601761 human embryonic stem cells .a 158 to 862 1 to 705 exact     705/705
(100 %)
0 diff
(100 %id)
TI_57167217   .a 158 to 821 34 to 715 C26S N39E F40L K41*     682/715
(95 %)
31 diff
(95.7 %id)
TI_57167278   .a 158 to 922 32 to 794 I90M D91M A92R M93*     763/794
(96 %)
7 diff
(99.2 %id)
EL947668 eyeball .a 159 to 740 1 to 581 exact     581/581
(100 %)
6 diff
(99.0 %id)
CT002031 T-Lymphocytes .a 159 to 830 1 to 673 exact     673/673
(100 %)
1 diff
(99.9 %id)
CR594934 fetal liver .a 160 to 1486 1 to 1327 exact     1327/1327
(100 %)
0 diff
(100 %id)
BX405553 fetal liver, Liver .a 160 to 570 1 to 411   fully sequenced,   411/411
(100 %)
0 diff
(100 %id)
BE958284 brain, primitive neuroectoderm .a 160 to 798 1 to 642 R30G V65S D66G N67*     638/915
(69 %)
42 diff
(95.5 %id)
BY995180   .a 160 to 908 8 to 756 exact     749/756
(99 %)
6 diff
(99.3 %id)
CR741672 Kidney .a 162 to 654 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BG742578 skin .a 162 to 974 1 to 812 exact     812/812
(100 %)
4 diff
(99.6 %id)
BM458940 melanotic melanoma, skin .a 162 to 1034 1 to 876 exact     876/1039
(84 %)
7 diff
(99.4 %id)
BF213732 bone marrow, from acute myelogenous leukemia .a 163 to 848 1 to 700 V49S R50*     695/880
(78 %)
37 diff
(95.8 %id)
DR157255 human embryonic stem cells differentiated toan early endodermal cell type .a 163 to 868 1 to 706 exact     706/706
(100 %)
0 diff
(100 %id)
BG531740 embryonal carcinoma, testis .a 164 to 778 1 to 627 Q101T K102E R103A Q104P A105S ...     623/857
(72 %)
42 diff
(95.1 %id)
BF669939 brain, primitive neuroectoderm .a 165 to 911 1 to 739 C32A K33N S34L K35N C36V ...     617/879
(70 %)
39 diff
(95.6 %id)
BE897262 melanotic melanoma, skin .a 167 to 923 1 to 757 exact     757/927
(81 %)
27 diff
(97.1 %id)
BU155589 melanotic melanoma, skin .a 167 to 1043 1 to 880 exact     880/885
(99 %)
4 diff
(99.6 %id)
CR598587 Placenta Cot 25-normalized .a 168 to 1476 1 to 1309 exact     1309/1309
(100 %)
0 diff
(100 %id)
AV661492 corresponding non cancerous liver tissue .a 168 to 780 1 to 613 exact   Submitted on the opposite strand 613/613
(100 %)
0 diff
(100 %id)
CT002927 T-Lymphocytes .a 168 to 1095 1 to 925 exact     925/927
(99 %)
7 diff
(99.3 %id)
TI_57189973   .a 169 to 1043 59 to 931 S10A     873/873
(100 %)
9 diff
(99.0 %id)
AF060926 brain .a 170 to 1507 1 to 1333 exact     1333/1333
(100 %)
4 diff
(99.7 %id)
BC012913 Bladder, transitional cell papilloma .a 170 to 1500 1 to 1331 exact available from MGC, AAA   1331/1331
(100 %)
1 diff
(100.0 %id)
TI_154162732   .a 171 to 895 80 to 809 exact     730/1224
(59 %)
9 diff
(99.3 %id)
TI_57191098   .a 172 to 917 134 to 877 C26A K27R V28C F29S R30D ...     744/744
(100 %)
4 diff
(99.5 %id)
TI_1948098675   .a 174 to 677 121 to 623 I3X C6X Y7I F8S C9V ...     503/539
(93 %)
12 diff
(97.8 %id)
TI_1948098663.
matches multiple genes
  .a 174 to 588 127 to 541     also hits gene gaglar 415/438
(94 %)
7 diff
(98.5 %id)
TI_1948098937   .a 174 to 677 126 to 629 C6X     504/604
(83 %)
12 diff
(98.1 %id)
AB462502   .a 178 to 893 26 to 740 exact     715/745
(95 %)
12 diff
(98.4 %id)
TI_1948083570   .a 179 to 677 132 to 630 Y7C F21C W86R     499/583
(85 %)
13 diff
(97.8 %id)
TI_1948098538   .a 179 to 677 620 to 121 C6V C9*     500/641
(78 %)
4 diff
(99.4 %id)
TI_1948098528   .a 179 to 677 625 to 126 Y7N H17R M20D F21V V22R ...     500/1388
(36 %)
5 diff
(99.7 %id)
TI_1948098815   .a 179 to 677 618 to 120 R2C I3F C6H F8L S10*     499/1411
(35 %)
12 diff
(99.2 %id)
TI_1948098801   .a 179 to 677 619 to 121 F29I E160D A162D     499/584
(85 %)
1 diff
(99.9 %id)
TI_1948098940   .a 179 to 677 616 to 119 D161M A162L P163L     498/717
(69 %)
1 diff
(99.9 %id)
TI_1948098926   .a 179 to 677 124 to 622 F29I     499/539
(92 %)
17 diff
(96.9 %id)
TI_1948216704   .a 179 to 677 126 to 623 N45D E146G D161V A162L P163L     498/683
(72 %)
14 diff
(98.0 %id)
TI_1948217030   .a 179 to 677 127 to 625 N45D E146G     499/674
(74 %)
13 diff
(98.1 %id)
CR457179   .a 180 to 671 1 to 492 exact     492/492
(100 %)
0 diff
(100 %id)
TI_1948098539   .a 180 to 677 130 to 627 Y7D     498/633
(78 %)
12 diff
(98.2 %id)
CN308321 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 181 to 876 1 to 697       697/697
(100 %)
1 diff
(99.9 %id)
TI_1948098673   .a 181 to 684 127 to 630       504/602
(83 %)
15 diff
(97.6 %id)
FN149730 breast carcinoma .a 182 to 288 104 to 1     Submitted on the opposite strand 104/104
(100 %)
4 diff
(96.2 %id)
TI_1948088909   .a 185 to 669 622 to 139     Submitted on the opposite strand 484/704
(68 %)
10 diff
(98.6 %id)
BF891707 marrow .a 197 to 447 1 to 250       250/270
(92 %)
9 diff
(96.7 %id)
CN308328 embryonic stem cells, DMSO-treated H9 cellline .a 197 to 746 1 to 550       550/550
(100 %)
0 diff
(100 %id)
CR591767 fetal brain .a 198 to 1947 1 to 1750   tiling clone,   1750/1750
(100 %)
0 diff
(100 %id)
TI_1948098812   .a 199 to 677 147 to 625       479/700
(68 %)
8 diff
(98.9 %id)
DA606131   .a 200 to 745 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BP199122 brain .a 205 to 791 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BP308330 brain .a 205 to 785 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CK825222 Pancreas, Purified pancreatic islet .a 208 to 757 1 to 550     Submitted on the opposite strand 550/550
(100 %)
0 diff
(100 %id)
AA774233 lung, lung carcinoma .a 215 to 569 1 to 355     Submitted on the opposite strand 355/355
(100 %)
0 diff
(100 %id)
BG612624 embryonal carcinoma, testis .a 216 to 806 1 to 591       591/591
(100 %)
0 diff
(100 %id)
AA034098 liver and spleen .a 218 to 350 1 to 133       133/133
(100 %)
0 diff
(100 %id)
BU078280 Pancreas, Purified pancreatic islet .a 223 to 710 1 to 488       488/488
(100 %)
0 diff
(100 %id)
CA866614 Pancreas, Purified pancreatic islet .a 223 to 803 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CA867990 Pancreas, Purified pancreatic islet .a 223 to 734 1 to 512       512/512
(100 %)
0 diff
(100 %id)
TI_154097528   .a 230 to 637 456 to 50       407/900
(45 %)
5 diff
(99.5 %id)
TI_154097809   .a 230 to 637 463 to 57       407/892
(45 %)
5 diff
(99.5 %id)
CX871091 embryonic stem .a 234 to 1141 1 to 908       908/908
(100 %)
0 diff
(100 %id)
BF132658 lung, mucoepidermoid carcinoma .a 258 to 935 1 to 677       677/681
(99 %)
3 diff
(99.6 %id)
TI_57216883   .a 259 to 1084 51 to 876       828/876
(94 %)
17 diff
(98.1 %id)
CN308329 embryonic stem cells, DMSO-treated H9 cellline .a 287 to 873 1 to 587       587/587
(100 %)
0 diff
(100 %id)
CD677312 eye, Trabecular meshwork .a 292 to 936 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BM711237 eye, fetal eyes .a 305 to 721 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BU619894 Cell Line, Chondrosarcoma .a 308 to 1032 742 to 19   AAA   724/724
(100 %)
3 diff
(99.6 %id)
TI_154105293   .a 340 to 1037 782 to 85   AAA   698/698
(100 %)
0 diff
(100 %id)
BX346925 Placenta Cot 25-normalized .a 346 to 1197 1 to 851       851/851
(100 %)
3 diff
(99.7 %id)
BG109774 Bone, osteosarcoma, cell line .a 348 to 1111 1 to 759       759/898
(84 %)
13 diff
(98.6 %id)
BI850405 Bone, osteosarcoma, cell line .a 348 to 1032 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
CX786427 human embryonic stem cells .a 355 to 1147 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
CA446566 Chondrosarcoma, Left Pubic Bone .a 361 to 1037 690 to 14   AAA   677/677
(100 %)
0 diff
(100 %id)
AA845425 parathyroid gland, parathyroid tumor .a 366 to 1032 677 to 12   AAA   666/767
(86 %)
8 diff
(99.0 %id)
CN308326 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 384 to 906 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BX347201   .a 395 to 1238 842 to 1       842/853
(98 %)
2 diff
(99.8 %id)
BG528537 adenocarcinoma, Prostate .a 413 to 1223 1 to 812       812/812
(100 %)
21 diff
(97.5 %id)
BQ954678 sciatic nerve .a 417 to 1330 1 to 915       915/916
(99 %)
13 diff
(98.6 %id)
BU167847 eye, retinoblastoma .a 427 to 1291 1 to 866       866/866
(100 %)
1 diff
(99.9 %id)
CA433003 mixed .a 433 to 1037 618 to 14   AAA   605/605
(100 %)
0 diff
(100 %id)
BF695582 brain, primitive neuroectoderm .a 437 to 1137 1 to 698       698/703
(99 %)
12 diff
(98.3 %id)
CD640760 pooled .a 440 to 1029 3 to 592       590/593
(99 %)
1 diff
(99.9 %id)
BM310822 Pancreas, Purified pancreatic islet .a 441 to 1016 10 to 585       576/585
(98 %)
0 diff
(100 %id)
BX407490 neuroblastoma .a 453 to 1494 1045 to 5       1041/1045
(99 %)
3 diff
(99.8 %id)
CB158420 Liver .a 462 to 1010 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CN308331 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 485 to 1088 1 to 604       604/604
(100 %)
0 diff
(100 %id)
TI_59393045   .a 509 to 1235 89 to 815       727/727
(100 %)
5 diff
(99.4 %id)
BF375236 stomach .a 510 to 816 332 to 22       311/357
(87 %)
2 diff
(99.5 %id)
CB134577 Liver .a 510 to 1037 556 to 29   AAA Submitted on the opposite strand 528/528
(100 %)
0 diff
(100 %id)
AW753677 colon .a 514 to 1162 654 to 2       653/654
(99 %)
5 diff
(99.3 %id)
CN308316 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 528 to 1018 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BF036863 adenocarcinoma, ovary .a 538 to 1211 1 to 674       674/678
(99 %)
1 diff
(99.9 %id)
BX448081 fetal liver, Liver .a 540 to 1480 948 to 7   fully sequenced,   942/948
(99 %)
0 diff
(100 %id)
CN308314 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 588 to 1308 1 to 723       723/723
(100 %)
2 diff
(99.8 %id)
BQ213270 melanotic melanoma, skin .a 592 to 1427 23 to 874       852/896
(95 %)
28 diff
(96.9 %id)
TI_149298714   .a 592 to 1507 982 to 84   AAA   899/951
(94 %)
21 diff
(97.8 %id)
TI_149309625   .a 597 to 1507 1000 to 101   AAA   900/962
(93 %)
16 diff
(98.4 %id)
TI_154108457   .a 597 to 1507 972 to 66   AAA   907/983
(92 %)
9 diff
(99.1 %id)
TI_154030229   .a 598 to 1507 977 to 77   AAA   901/986
(91 %)
12 diff
(98.8 %id)
TI_154059076   .a 598 to 1507 979 to 79   AAA   901/1019
(88 %)
17 diff
(98.4 %id)
N33154 melanocyte .a 607 to 1032 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA165406   .a 614 to 1136 1 to 519   fully sequenced,   519/519
(100 %)
3 diff
(99.5 %id)
TI_149286939   .a 614 to 1507 943 to 61   AAA   883/1093
(80 %)
23 diff
(97.9 %id)
BM761164 lymph node, stomach .a 616 to 1284 1 to 669       669/669
(100 %)
0 diff
(100 %id)
AA652132 alveolar rhabdomyosarcoma .a 626 to 1036 419 to 9       411/420
(97 %)
0 diff
(100 %id)
AI278870 carcinoid, lung .a 632 to 1038 415 to 9       407/415
(98 %)
0 diff
(100 %id)
AI367354 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 633 to 1032 400 to 1       400/400
(100 %)
0 diff
(100 %id)
H99743 melanocyte .a 635 to 1032 398 to 1       398/398
(100 %)
0 diff
(100 %id)
TI_154032281   .a 636 to 1507 944 to 83   AAA   862/933
(92 %)
16 diff
(98.3 %id)
AA652354 alveolar rhabdomyosarcoma .a 644 to 1036 399 to 7       393/399
(98 %)
0 diff
(100 %id)
AA864915 pooled germ cell tumors .a 658 to 1038 389 to 9       381/389
(97 %)
0 diff
(100 %id)
BG613616 embryonal carcinoma, testis .a 663 to 1493 1 to 824       824/853
(96 %)
19 diff
(97.8 %id)
AA649770 alveolar rhabdomyosarcoma .a 670 to 1036 379 to 13       367/379
(96 %)
0 diff
(100 %id)
TI_149305828   .a 688 to 1507 891 to 79   AAA   813/937
(86 %)
15 diff
(98.4 %id)
TI_154111700   .a 694 to 1507 890 to 84   AAA   807/930
(86 %)
12 diff
(98.8 %id)
AI085005 liver and spleen .a 695 to 1037 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BG032023 breast, mammary adenocarcinoma, cell line .a 697 to 1493 1 to 788       788/930
(84 %)
21 diff
(97.8 %id)
TI_149299254   .a 712 to 1507 876 to 85   AAA   792/792
(100 %)
29 diff
(96.4 %id)
BG950893 colon .a 713 to 1055 455 to 110       346/455
(76 %)
0 diff
(100 %id)
AA431846   .a 722 to 1250 1 to 529       529/529
(100 %)
0 diff
(100 %id)
CV370772 testis_normal .a 726 to 1159 448 to 7     Submitted on the opposite strand 442/448
(98 %)
0 diff
(100 %id)
BU680185 lung, Primary Lung Epithelial Cells .a 736 to 1407 1 to 672     Submitted on the opposite strand 672/681
(98 %)
8 diff
(98.9 %id)
GD139125   .a 738 to 888 151 to 1     Submitted on the opposite strand 151/152
(99 %)
6 diff
(96.1 %id)
BX411891 neuroblastoma .a 739 to 1522 790 to 1       790/854
(92 %)
36 diff
(95.8 %id)
CA442443 Fibrosarcoma .a 746 to 1507 780 to 19   AAA   762/762
(100 %)
1 diff
(99.9 %id)
T30094 adrenal gland, Bone .a 753 to 1055 1 to 303       303/303
(100 %)
0 diff
(100 %id)
BF989454 placenta_normal .a 764 to 1091 378 to 50       329/378
(87 %)
0 diff
(100 %id)
BM907488 large cell carcinoma, lung .a 764 to 1507 760 to 16   AAA Submitted on the opposite strand 745/746
(99 %)
3 diff
(99.6 %id)
CA447579 Chondrosarcoma, Left Pelvis .a 765 to 1507 761 to 19   AAA   743/743
(100 %)
1 diff
(99.9 %id)
BM999399 Fibrosarcoma .a 770 to 1507 756 to 19   AAA   738/738
(100 %)
0 diff
(100 %id)
CA448516 Chondrosarcoma, Left Pelvis .a 770 to 1507 756 to 19   AAA   738/738
(100 %)
0 diff
(100 %id)
BQ575123 Chondrosarcoma Grade II, Left Pelvis .a 770 to 1507 756 to 19   AAA   738/738
(100 %)
1 diff
(99.9 %id)
BU631577 cell lines, Chondrosarcoma .a 770 to 1507 756 to 19   AAA   738/738
(100 %)
4 diff
(99.5 %id)
CB142504 Liver .a 774 to 1370 1 to 597       597/597
(100 %)
0 diff
(100 %id)
CA442954 Fibrosarcoma .a 785 to 1507 741 to 19   AAA   723/732
(98 %)
0 diff
(100 %id)
BP225778   .a 786 to 1368 1 to 583       583/583
(100 %)
0 diff
(100 %id)
TI_149284884   .a 803 to 1507 797 to 93   AAA   705/706
(99 %)
7 diff
(99.1 %id)
BM972346 lung .a 809 to 1507 717 to 19   AAA   699/699
(100 %)
2 diff
(99.8 %id)
CA419482 Bone, Human Chondrosarcoma Cell Line .a 809 to 1507 717 to 19   AAA   699/699
(100 %)
0 diff
(100 %id)
TI_149294884   .a 819 to 1507 772 to 84   AAA   689/1006
(68 %)
2 diff
(99.9 %id)
BQ006119 Chondrosarcoma, Left Pelvis .a 826 to 1507 699 to 19   AAA   681/681
(100 %)
3 diff
(99.6 %id)
W79352 heart .a 827 to 1216 1 to 395   fully sequenced,   395/395
(100 %)
2 diff
(99.5 %id)
BU626046 cell lines, Enchondroma .a 836 to 1507 690 to 19   AAA   672/672
(100 %)
0 diff
(100 %id)
BM666218 eye, fetal eyes .a 840 to 1507 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
CR615334 Neuroblastoma Cot 10-normalized .a 843 to 1493 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BX352748 Neuroblastoma Cot 10-normalized .a 843 to 1509 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
BX370826 Neuroblastoma Cot 10-normalized .a 843 to 1473 633 to 1       633/633
(100 %)
7 diff
(98.9 %id)
BX370827 Neuroblastoma Cot 10-normalized .a 843 to 1509 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
BX370828 Neuroblastoma Cot 10-normalized .a 843 to 1500 1 to 657       657/664
(98 %)
2 diff
(99.7 %id)
CR748480 Kidney .a 844 to 1324 1 to 481       481/481
(100 %)
0 diff
(100 %id)
CB156918 Liver .a 847 to 1247 1 to 401       401/401
(100 %)
0 diff
(100 %id)
AA034241 uterus .a 850 to 1012 1 to 163       163/163
(100 %)
0 diff
(100 %id)
BX429175 neuroblastoma .a 858 to 1507 1 to 649       649/649
(100 %)
3 diff
(99.6 %id)
BX429373 brain, fetal brain .a 858 to 1701 1 to 834       834/859
(97 %)
20 diff
(97.7 %id)
BX388684   .a 863 to 1699 1 to 823       823/873
(94 %)
40 diff
(95.5 %id)
BX370825 Neuroblastoma Cot 10-normalized .a 876 to 1509 633 to 1       633/667
(94 %)
39 diff
(94.2 %id)
FN125662 breast carcinoma .a 881 to 985 1 to 108       108/108
(100 %)
3 diff
(97.3 %id)
BE843289 testis_normal .a 883 to 1137 259 to 5       255/259
(98 %)
0 diff
(100 %id)
BM510773 insulinoma, Pancreas .a 896 to 1507 625 to 14   AAA   612/612
(100 %)
0 diff
(100 %id)
BM310514 Pancreas, Purified pancreatic islet .a 901 to 1506 606 to 1       606/606
(100 %)
0 diff
(100 %id)
CA866879 Pancreas, Purified pancreatic islet .a 904 to 1509 609 to 4       606/609
(99 %)
0 diff
(100 %id)
CK825223 Pancreas, Purified pancreatic islet .a 906 to 1507 619 to 18   AAA Submitted on the opposite strand 602/602
(100 %)
1 diff
(99.9 %id)
TI_149293452   .a 922 to 1507 671 to 86   AAA   586/951
(61 %)
0 diff
(100 %id)
CA868237 Pancreas, Purified pancreatic islet .a 936 to 1506 571 to 1       571/571
(100 %)
1 diff
(99.9 %id)
DN919393   .a 945 to 1514 616 to 47   AAA   570/570
(100 %)
7 diff
(98.8 %id)
AA300979 testis .a 946 to 1215 1 to 270       270/270
(100 %)
0 diff
(100 %id)
AI744021 Kidney .a 947 to 1508 562 to 1       562/562
(100 %)
0 diff
(100 %id)
BG230748 blood, lymphocyte .a 948 to 1508 561 to 1       561/561
(100 %)
0 diff
(100 %id)
DB320049   .a 950 to 1500 551 to 1       551/551
(100 %)
0 diff
(100 %id)
CB134460 Liver .a 963 to 1507 562 to 18   AAA Submitted on the opposite strand 545/545
(100 %)
0 diff
(100 %id)
AA581888 germ cell tumor .a 964 to 1507 544 to 1       544/544
(100 %)
0 diff
(100 %id)
AW197140 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 986 to 1508 523 to 1       523/523
(100 %)
0 diff
(100 %id)
BM667921 eye, lens .a 986 to 1507 541 to 20   AAA   522/522
(100 %)
1 diff
(99.9 %id)
AW088741 ovary, tumor, 5 pooled (see description) .a 991 to 1508 518 to 1       518/518
(100 %)
0 diff
(100 %id)
AW512258 lymph node, lymphoma, follicular mixed small and largecell .a 992 to 1509 518 to 1       518/518
(100 %)
0 diff
(100 %id)
BX408584 neuroblastoma .a 1011 to 1507 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
BE043947 lymph node, lymphoma, follicular mixed small and largecell .a 1018 to 1508 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI571376 anaplastic oligodendroglioma, brain .a 1021 to 1507 487 to 1       487/487
(100 %)
0 diff
(100 %id)
CB114621 Liver .a 1027 to 1507 514 to 34   AAA Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AW273159 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1043 to 1507 465 to 1       465/465
(100 %)
0 diff
(100 %id)
CB135331 Liver .a 1051 to 1507 507 to 51   AAA Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
AI742265 pooled .a 1057 to 1500 460 to 17   AAA   444/444
(100 %)
0 diff
(100 %id)
AI636278 Kidney .a 1058 to 1509 452 to 1       452/452
(100 %)
0 diff
(100 %id)
D62512   .a 1065 to 1432 1 to 368       368/368
(100 %)
0 diff
(100 %id)
AA594795 breast .a 1067 to 1505 439 to 1       439/439
(100 %)
0 diff
(100 %id)
DB525268 testis .a 1068 to 1507 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI719503 aorta .a 1071 to 1500 430 to 1       430/430
(100 %)
0 diff
(100 %id)
BE092855 breast .a 1078 to 1475 408 to 6     Submitted on the opposite strand 403/408
(98 %)
0 diff
(100 %id)
AI539174 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1078 to 1508 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI573041 lymph node, lymphoma, follicular mixed small and largecell .a 1086 to 1509 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AI498347 Kidney .a 1087 to 1507 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AW591122 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1088 to 1507 420 to 1       420/420
(100 %)
0 diff
(100 %id)
T31394 colon, embryo .a 1097 to 1391 1 to 295       295/295
(100 %)
0 diff
(100 %id)
AI281747 colon, moderately-differentiated adenocarcinoma .a 1098 to 1507 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI250273 lymph node, lymphoma, follicular mixed small and largecell .a 1098 to 1507 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI189253 uterus .a 1100 to 1507 408 to 1       408/408
(100 %)
0 diff
(100 %id)
BE646030 Prostate .a 1104 to 1507 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BP431338   .a 1104 to 1466 1 to 363       363/363
(100 %)
0 diff
(100 %id)
AA165407   .a 1106 to 1509 404 to 1   fully sequenced,   404/404
(100 %)
0 diff
(100 %id)
AI200413 lung .a 1113 to 1507 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AA722100 pineal gland .a 1121 to 1503 383 to 1       383/383
(100 %)
0 diff
(100 %id)
DB510190 testis .a 1132 to 1506 1 to 376     Submitted on the opposite strand 376/377
(99 %)
7 diff
(98.2 %id)
AA044690 uterus .a 1138 to 1508 1 to 373   fully sequenced,   373/373
(100 %)
3 diff
(99.2 %id)
AI867798 pooled germ cell tumors .a 1138 to 1500 376 to 14   AAA   363/363
(100 %)
0 diff
(100 %id)
AA708943 uterus .a 1140 to 1509 370 to 1       370/370
(100 %)
0 diff
(100 %id)
AA443890 ovarian tumor, ovary .a 1144 to 1508 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AA609789 lung, lung carcinoma .a 1144 to 1509 366 to 1       366/366
(100 %)
0 diff
(100 %id)
AW969812   .a 1146 to 1507 449 to 88   AAA Submitted on the opposite strand 362/362
(100 %)
1 diff
(99.8 %id)
Z39345 brain, total brain .a 1151 to 1500 350 to 1       350/350
(100 %)
0 diff
(100 %id)
TI_149281508   .a 1152 to 1509 123 to 480     Submitted on the opposite strand 358/869
(41 %)
6 diff
(99.4 %id)
TI_149304590   .a 1152 to 1509 156 to 513     Submitted on the opposite strand 358/1072
(33 %)
6 diff
(99.5 %id)
BM971226 lung, Primary Lung Epithelial Cells .a 1152 to 1509 89 to 446     Submitted on the opposite strand 358/461
(77 %)
6 diff
(98.7 %id)
CB854480 lung, Primary Lung Epithelial Cells .a 1152 to 1509 89 to 446     Submitted on the opposite strand 358/461
(77 %)
6 diff
(98.7 %id)
AA374175 lung .a 1157 to 1507 352 to 1     Submitted on the opposite strand 352/352
(100 %)
1 diff
(99.8 %id)
AA828194 colon, colon tumor .a 1158 to 1500 362 to 20   AAA   343/343
(100 %)
0 diff
(100 %id)
TI_57202825   .a 1162 to 1508 32 to 379       348/571
(60 %)
6 diff
(99.0 %id)
F10645.
matches multiple genes
brain, total brain .a 1176 to 1500 325 to 1     also hits gene ATF2andCHN1 325/325
(100 %)
0 diff
(100 %id)
BF448921 sympathetic trunk .a 1180 to 1509 330 to 1       330/330
(100 %)
0 diff
(100 %id)
AI269009 Kidney .a 1181 to 1507 327 to 1       327/327
(100 %)
0 diff
(100 %id)
W74059 heart .a 1186 to 1507 322 to 1   fully sequenced,   322/322
(100 %)
0 diff
(100 %id)
AA829079 ovary .a 1201 to 1509 315 to 7       309/315
(98 %)
0 diff
(100 %id)
AI805098 Prostate .a 1208 to 1507 300 to 1       300/300
(100 %)
0 diff
(100 %id)
BF093677 uterus .a 1212 to 1328 8 to 123       116/123
(94 %)
6 diff
(95.2 %id)
F04672 brain, total brain .a 1244 to 1500 257 to 1       257/257
(100 %)
0 diff
(100 %id)
AI708771 aorta .a 1250 to 1500 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AW614180 Kidney .a 1270 to 1507 238 to 1       238/238
(100 %)
0 diff
(100 %id)
BP426093 small intestine .a 1275 to 1505 1 to 231     Submitted on the opposite strand 231/231
(100 %)
0 diff
(100 %id)
AI766125 Kidney .a 1277 to 1405 129 to 1       129/129
(100 %)
0 diff
(100 %id)
AA044901 uterus .a 1280 to 1509 230 to 1   fully sequenced,   230/230
(100 %)
0 diff
(100 %id)
FN150052 breast carcinoma .a 1302 to 1401 1 to 105       105/115
(91 %)
7 diff
(94.0 %id)
AI689518 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1303 to 1507 205 to 1       205/205
(100 %)
0 diff
(100 %id)
BY796170 eye .a 1329 to 1927 1 to 599       599/599
(100 %)
0 diff
(100 %id)
AI364247 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1333 to 1507 175 to 1       175/175
(100 %)
0 diff
(100 %id)
AW768878 colon, moderately-differentiated adenocarcinoma .a 1354 to 1507 154 to 1       154/154
(100 %)
0 diff
(100 %id)
EC502832 Prostate .a 1369 to 1500 132 to 2       131/132
(99 %)
0 diff
(100 %id)
AI364605 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1371 to 1508 138 to 1       138/138
(100 %)
0 diff
(100 %id)
EC440313 Prostate .a 1372 to 1507 135 to 1       135/135
(100 %)
1 diff
(99.3 %id)
BU535094 mixed (pool of 40 RNAs) .a 1403 to 1507 1 to 105   AAA   105/105
(100 %)
2 diff
(98.1 %id)
DB459822 testis .b 1 to 442 1 to 442 exact tiling clone,   442/442
(100 %)
0 diff
(100 %id)
CR981404 T-Lymphocytes .c 1 to 935 1 to 935 Q62X tiling clone,   935/940
(99 %)
2 diff
(99.8 %id)
DW456897 Liver .c 261 to 410 17 to 166       150/166
(90 %)
6 diff
(96.4 %id)
BU853634 testis .d 1 to 794 1 to 799 K71E tiling clone,   799/799
(100 %)
15 diff
(98.2 %id)
BG545947 lung .e 1 to 666 1 to 668 exact tiling clone,   668/668
(100 %)
4 diff
(99.5 %id)
DB445170 testis .f 1 to 435 1 to 435 T17N R21G tiling clone,   435/435
(100 %)
2 diff
(99.6 %id)
DA229334 brain Gene RSL24D1, variant not shown       capped      
DB325509 tongue Gene RSL24D1, variant not shown              
DA767272 tongue Gene RSL24D1, variant not shown       capped      
TI_154100988   Gene RSL24D1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI